|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Figueroa JD, Ye Y, Siddiq A, Garcia-Closas
M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C,
Cussenot O, Benhamou S, et al: Genome-wide association study
identifies multiple loci associated with bladder cancer risk. Hum
Mol Genet. 23:1387–1398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Lu T, Du L, Hu Z, Zhuang Q, Li Y,
Wang CY, Zhu H and Ye Z: Plasmacytoid urothelial carcinoma of the
urinary bladder: A clinical pathological study and literature
review. Int J Clin Exp Pathol. 5:601–608. 2012.PubMed/NCBI
|
|
5
|
Kanojia D, Garg M, Saini S, Agarwal S,
Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, et
al: Sperm associated antigen 9 plays an important role in bladder
transitional cell carcinoma. PLoS One. 8:e813482013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patchsung M, Boonla C, Amnattrakul P,
Dissayabutra T, Mutirangura A and Tosukhowong P: Long interspersed
nuclear element-1 hypomethylation and oxidative stress: Correlation
and bladder cancer diagnostic potential. PLoS One. 7:e370092012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Redondo-Gonzalez E, de Castro LN,
Moreno-Sierra J, de las Casas ML Maestro, Vera-Gonzalez V, Ferrari
DG and Corchado JM: Bladder carcinoma data with clinical risk
factors and molecular markers: A cluster analysis. Biomed Res Int.
2015:1686822015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gakis G: The role of inflammation in
bladder cancer. Adv Exp Med Biol. 816:183–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gecit I, Aslan M, Gunes M, Pirincci N,
Esen R, Demir H and Ceylan K: Serum prolidase activity, oxidative
stress, and nitric oxide levels in patients with bladder cancer. J
Cancer Res Clin Oncol. 138:739–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Li S, Liu Y and Ma C: Redox
regulated peroxisome homeostasis. Redox Biol. 4:104–108. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Le Lay S, Simard G, Martinez MC and
Andriantsitohaina R: Oxidative stress and metabolic pathologies:
From an adipocentric point of view. Oxid Med Cell Longev.
2014:9085392014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thanan R, Oikawa S, Hiraku Y, Ohnishi S,
Ma N, Pinlaor S, Yongvanit P, Kawanishi S and Murata M: Oxidative
stress and its significant roles in neurodegenerative diseases and
cancer. Int J Mol Sci. 16:193–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chaudhari N, Talwar P, Parimisetty A,
d'Hellencourt C Lefebvre and Ravanan P: A molecular web:
Endoplasmic reticulum stress, inflammation, and oxidative stress.
Front Cell Neurosci. 8:2132014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y,
Xiao J, Qian L, Zhao W, Liu Q, et al: miR-193a-3p regulates the
multi-drug resistance of bladder cancer by targeting the LOXL4 gene
and the oxidative stress pathway. Mol Cancer. 13:2342014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Higgins JA, Zainol M, Brown K and Jones
GD: Anthocyans as tertiary chemopreventive agents in bladder
cancer: Anti-oxidant mechanisms and interaction with mitomycin C.
Mutagenesis. 29:227–235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ellidag HY, Eren E, Aydin O, Akgol E,
Yalcinkaya S, Sezer C and Yilmaz N: Ischemia modified albumin
levels and oxidative stress in patients with bladder cancer. Asian
Pac J Cancer Prev. 14:2759–2763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Savic-Radojevic A, Djukic T, Simic T,
Pljesa-Ercegovac M, Dragicevic D, Pekmezovic T, Cekerevac M,
Santric V and Matic M: GSTM1-null and GSTA1-low activity genotypes
are associated with enhanced oxidative damage in bladder cancer.
Redox Rep. 18:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amasyali AS, Kucukgergin C, Erdem S, Sanli
O, Seckin S and Nane I: Nitric oxide synthase (eNOS4a/b) gene
polymorphism is associated with tumor recurrence and progression in
superficial bladder cancer cases. J Urol. 188:2398–2403. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soini Y, Haapasaari KM, Vaarala MH,
Turpeenniemi-Hujanen T, Kärjä V and Karihtala P:
8-hydroxydeguanosine and nitrotyrosine are prognostic factors in
urinary bladder carcinoma. Int J Clin Exp Pathol. 4:267–275.
2011.PubMed/NCBI
|
|
20
|
Yilmaz IA, Akçay T, Cakatay U, Telci A,
Ataus S and Yalçin V: Relation between bladder cancer and protein
oxidation. Int Urol Nephrol. 35:345–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Badjatia N, Satyam A, Singh P, Seth A and
Sharma A: Altered antioxidant status and lipid peroxidation in
Indian patients with urothelial bladder carcinoma. Urol Oncol.
28:360–367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yalçin O, Karataş F, Erulaş FA and Ozdemir
E: The levels of glutathione peroxidase, vitamin AE, C and lipid
peroxidation in patients with transitional cell carcinoma of the
bladder. BJU Int. 93:863–866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abat D, Demirhan O, Inandiklioglu N, Tunc
E, Erdogan S, Tastemir D, Uslu IN and Tansug Z: Genetic alterations
of chromosomes, p53 and p16 genes in low- and high-grade bladder
cancer. Oncol Lett. 8:25–32. 2014.PubMed/NCBI
|
|
24
|
Lopez-Beltran A, Santoni M, Massari F,
Ciccarese C, Tortora G, Cheng L, Moch H, Scarpelli M, Reymundo C
and Montironi R: Bladder cancer: Molecular determinants of
personalized therapy. Curr Drug Targets. 16:115–124. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drayton RM, Peter S, Myers K, Miah S,
Dudziec E, Bryant HE and Catto JW: MicroRNA-99a and 100 mediated
upregulation of FOXA1 in bladder cancer. Oncotarget. 5:6375–6386.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wieczorek E, Wasowicz W, Gromadzinska J
and Reszka E: Functional polymorphisms in the matrix
metalloproteinase genes and their association with bladder cancer
risk and recurrence: A mini-review. Int J Urol. 21:744–752. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morrison CD, Liu P, Woloszynska-Read A,
Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P,
et al: Whole-genome sequencing identifies genomic heterogeneity at
a nucleotide and chromosomal level in bladder cancer. Proc Natl
Acad Sci USA. 111:pp. E672–E681. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Campos SR, Melo TC, Assaf S, Araldi RP,
Mazzuchelli-de-Souza J, Sircili MP, Carvalho RF, Roperto F, Beçak W
and Stocco RC: Chromosome aberrations in cells infected with bovine
papillomavirus: Comparing cutaneous papilloma, esophagus papilloma,
and urinary bladder lesion cells. ISRN Oncol.
2013:9108492013.PubMed/NCBI
|
|
29
|
Köhler CU, Martin L, Bonberg N, Behrens T,
Deix T, Braun K, Noldus J, Jöckel KH, Erbel R, Sommerer F, et al:
Automated quantification of FISH signals in urinary cells enables
the assessment of chromosomal aberration patterns characteristic
for bladder cancer. Biochem Biophys Res Commun. 448:467–472. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bonberg N, Taeger D, Gawrych K, Johnen G,
Banek S, Schwentner C, Sievert KD, Wellhäußer H, Kluckert M, Leng
G, et al: Chromosomal instability and bladder cancer: The
UroVysion(TM) test in the UroScreen study. BJU Int. 112:E372–E382.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM Classification of Malignant Tumours. Urological TumoursRenal
Pelvis and Ureter. Wiley-Blackwell; 2009
|
|
32
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: World Health Organization classification of tumours:
Pathology and genetics of head and neck tumours. Lyon: IARC; pp.
168–175. 2005
|
|
33
|
Erel O: A new automated colorimetric
method for measuring total oxidant status. Clin Biochem.
38:1103–1111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Harma M, Harma M and Erel O: Oxidative
stress in women with preeclampsia. Am J Obstet Gynecol.
192:656–657. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aycicek A, Erel O and Kocyigit A:
Decreased total antioxidant capacity and increased oxidative stress
in passive smoker infants and their mothers. Pediatr Int.
47:635–639. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aycicek A and Erel O: Total
oxidant/antioxidant status in jaundiced newborns before and after
phototherapy. J Pediatr (Rio J). 83:319–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dwivedi AN, Jain S and Dixit R: Gall
bladder carcinoma: Aggressive malignancy with protean loco-regional
and distant spread. World J Clin Cases. 3:231–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kwak KW, Kim SH and Lee HM: The utility of
fluorescence in situ hybridization for detection of bladder
urothelial carcinoma in routine clinical practice. J Korean Med
Sci. 24:1139–1144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Caraway NP, Khanna A, Fernandez RL, Payne
L, Bassett RL Jr, Zhang HZ, Kamat A and Katz RL: Fluorescence in
situ hybridization for detecting urothelial carcinoma: A
clinicopathologic study. Cancer Cytopathol. 118:259–268. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Caraway NP and Katz RL: A review on the
current state of urine cytology emphasizing the role of
fluorescence in situ hybridization as an adjunct to diagnosis.
Cancer Cytopathol. 118:175–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Feng JF, Lu L, Zeng P, Yang YH, Luo J,
Yang YW and Wang D: Serum total oxidant/antioxidant status and
trace element levels in breast cancer patients. Int J Clin Oncol.
17:575–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang D, Feng JF, Zeng P, Yang YH, Luo J
and Yang YW: Total oxidant/antioxidant status in sera of patients
with thyroid cancers. Endocr Relat Cancer. 18:773–782. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cumurcu BE, Ozyurt H, Etikan I, Demir S
and Karlidag R: Total antioxidant capacity and total oxidant status
in patients with major depression: Impact of antidepressant
treatment. Psychiatry Clin Neurosci. 63:639–645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Salim EI, Morimura K, Menesi A, El-Lity M,
Fukushima S and Wanibuchi H: Elevated oxidative stress and DNA
damage and repair levels in urinary bladder carcinomas associated
with schistosomiasis. Int J Cancer. 123:601–608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vadhanam MV, Thaiparambil J, Gairola CG
and Gupta RC: Oxidative DNA adducts detected in vitro from redox
activity of cigarette smoke constituents. Chem Res Toxicol.
25:2499–2504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bellavia M, Gioviale MC, Damiano G,
Palumbo VD, Spinelli G, Buscemi G and Lo Monte AI: Dissecting the
different biological effects of oncogenic Ras isoforms in cancer
cell lines: Could stimulation of oxidative stress be the one more
weapon of H-Ras? Regulation of oxidative stress and Ras biological
effects. Med Hypotheses. 79:731–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Guo S, Mao X, Chen J, Huang B, Jin C, Xu Z
and Qiu S: Overexpression of Pim-1 in bladder cancer. J Exp Clin
Cancer Res. 29:1612010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li S, Peng Q, Chen Y, You J, Chen Z, Deng
Y, Lao X, Wu H, Qin X and Zeng Z: DNA repair gene XRCC1
polymorphisms, smoking, and bladder cancer risk: A meta-analysis.
PLoS One. 8:e734482013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang D, Liu C, Shi J, Wang N, Du X, Yin Q
and Wang Y: Association of XRCC1 Arg399Gln polymorphism with
bladder cancer susceptibility: A meta-analysis. Gene. 534:17–23.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McKenna DJ, Doherty BA, Downes CS, McKeown
SR and McKelvey-Martin VJ: Use of the comet-FISH assay to compare
DNA damage and repair in p53 and hTERT genes following ionizing
radiation. PLoS One. 7:e493642012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ke Z, Lai Y, Ma X, Lil S and Huang W:
Diagnosis of bladder cancer from the voided urine specimens using
multi-target fluorescence hybridization. Oncol Lett. 7:325–330.
2014.PubMed/NCBI
|
|
52
|
Jenkins NC, Liu T, Cassidy P, Leachman SA,
Boucher KM, Goodson AG, Samadashwily G and Grossman D: The p16
(INK4A) tumor suppressor regulates cellular oxidative stress.
Oncogene. 30:265–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rayess H, Wang MB and Srivatsan ES:
Cellular senescence and tumor suppressor gene p16. Int J Cancer.
130:1715–1725. 2012. View Article : Google Scholar : PubMed/NCBI
|
